Cargando…
Chemotherapy and radiation therapy elicits tumor specific T cell responses in a breast cancer patient
BACKGROUND: Experimental evidence and clinical studies in breast cancer suggest that some anti-tumor therapy regimens generate stimulation of the immune system that accounts for tumor clinical responses, however, demonstration of the immunostimulatory power of these therapies on cancer patients cont...
Autores principales: | Bernal-Estévez, David, Sánchez, Ramiro, Tejada, Rafael E., Parra-López, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971722/ https://www.ncbi.nlm.nih.gov/pubmed/27484900 http://dx.doi.org/10.1186/s12885-016-2625-2 |
Ejemplares similares
-
Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy
por: Bernal-Estévez, David A., et al.
Publicado: (2018) -
An immune surveillance model to monitor the response to neo-adjuvant chemotherapy treatment in breast cancer patients
por: Bernal-Estévez, David A, et al.
Publicado: (2015) -
Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial
por: Bernal-Estévez, David A., et al.
Publicado: (2021) -
Neoadjuvant chemotherapy modulates exhaustion of T cells in breast cancer patients
por: Rodríguez, Ivon Johanna, et al.
Publicado: (2023) -
Macrophage biology plays a central role during ionizing radiation-elicited tumor response
por: Wu, Qiuji, et al.
Publicado: (2017)